Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01378260 · ClinicalTrials.gov registry record

Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)

A clinical trial, sponsored by University of Washington.

Completed
Registry status
323
Enrollment target

NCT01378260 is a clinical trial that has completed, run by University of Washington. The registered enrollment target is 323 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01378260 has completed, sponsored by University of Washington.

COMPLETED
Registry status
323 participants
Enrollment target

Study Summary

The specific aim of this study is to prospectively compare outcomes (functional, quality of life, risk-adjusted clinical event) of medical management, surgical or endovascular (angioplasty or stent placement) interventions for the treatment of claudication caused by peripheral arterial disease. This study will test two major hypotheses; Hypothesis 1: At 12-months, surgical interventions are associated with greater improvements in function, claudication symptoms, and health-related quality of life (HRQoL) than endovascular procedures or medical management. Hypothesis 2: At 12-months, surgical and endovascular interventions are associated with greater improvements in function, claudication symptoms, and HRQoL than medical management.

Trial Details

FieldValue
Enrollment Target 323 participants
Start Date 2011-07
Est. Completion 2015-08

Sponsor

University of Washington

1,048 total trials

What the Registry Record Tells You About NCT01378260

The ClinicalTrials.gov registry entry for NCT01378260 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 323 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01378260 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01378260 about?

NCT01378260 is a clinical study titled "Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)". The specific aim of this study is to prospectively compare outcomes (functional, quality of life, risk-adjusted clinical event) of medical management, surgical or endovascular (angioplasty or stent placement) interventions for the treatment of claudication caused by peripheral arterial disease. This...

What is the current status of trial NCT01378260?

This trial is currently completed. The enrollment target is 323 participants. The study started on 2011-07. Estimated completion is 2015-08.

Who is sponsoring clinical trial NCT01378260?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.